company background image
ELMD

Electromed NYSEAM:ELMD Stock Report

Last Price

US$10.25

Market Cap

US$86.9m

7D

1.4%

1Y

-4.3%

Updated

01 Oct, 2022

Data

Company Financials +
ELMD fundamental analysis
Snowflake Score
Valuation0/6
Future Growth3/6
Past Performance2/6
Financial Health6/6
Dividends0/6

ELMD Stock Overview

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally.

Electromed Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Electromed
Historical stock prices
Current Share PriceUS$10.25
52 Week HighUS$13.46
52 Week LowUS$8.75
Beta0.57
1 Month Change10.81%
3 Month Change3.54%
1 Year Change-4.30%
3 Year Change62.70%
5 Year Change42.56%
Change since IPO157.54%

Recent News & Updates

Shareholder Returns

ELMDUS Medical EquipmentUS Market
7D1.4%-1.8%-2.5%
1Y-4.3%-31.2%-23.2%

Return vs Industry: ELMD exceeded the US Medical Equipment industry which returned -31.2% over the past year.

Return vs Market: ELMD exceeded the US Market which returned -23.2% over the past year.

Price Volatility

Is ELMD's price volatile compared to industry and market?
ELMD volatility
ELMD Average Weekly Movement6.3%
Medical Equipment Industry Average Movement8.5%
Market Average Movement6.9%
10% most volatile stocks in US Market15.6%
10% least volatile stocks in US Market2.8%

Stable Share Price: ELMD is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: ELMD's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1992156Kathleen Skarvanhttps://smartvest.com

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting.

Electromed Fundamentals Summary

How do Electromed's earnings and revenue compare to its market cap?
ELMD fundamental statistics
Market CapUS$86.87m
Earnings (TTM)US$2.31m
Revenue (TTM)US$41.66m

37.7x

P/E Ratio

2.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ELMD income statement (TTM)
RevenueUS$41.66m
Cost of RevenueUS$10.22m
Gross ProfitUS$31.44m
Other ExpensesUS$29.14m
EarningsUS$2.31m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.27
Gross Margin75.47%
Net Profit Margin5.53%
Debt/Equity Ratio0%

How did ELMD perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is ELMD undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ELMD?

Other financial metrics that can be useful for relative valuation.

ELMD key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.9x
Enterprise Value/EBITDA21.9x
PEG Ratio1.9x

Price to Earnings Ratio vs Peers

How does ELMD's PE Ratio compare to its peers?

ELMD PE Ratio vs Peers
The above table shows the PE ratio for ELMD vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average11.2x
FONR FONAR
8xn/aUS$94.5m
PDEX Pro-Dex
16.6x19.2%US$64.1m
SRTS Sensus Healthcare
8.3x-29.9%US$207.4m
DXR Daxor
11.9xn/aUS$53.6m
ELMD Electromed
37.7x19.7%US$86.9m

Price-To-Earnings vs Peers: ELMD is expensive based on its Price-To-Earnings Ratio (37.7x) compared to the peer average (11.2x).


Price to Earnings Ratio vs Industry

How does ELMD's PE Ratio compare vs other companies in the US Medical Equipment Industry?

Price-To-Earnings vs Industry: ELMD is expensive based on its Price-To-Earnings Ratio (37.7x) compared to the US Medical Equipment industry average (32.6x)


Price to Earnings Ratio vs Fair Ratio

What is ELMD's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ELMD PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio37.7x
Fair PE Ratio20.1x

Price-To-Earnings vs Fair Ratio: ELMD is expensive based on its Price-To-Earnings Ratio (37.7x) compared to the estimated Fair Price-To-Earnings Ratio (20.1x).


Share Price vs Fair Value

What is the Fair Price of ELMD when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate ELMD's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate ELMD's fair value for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.


Discover undervalued companies

Future Growth

How is Electromed forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

Future Growth Score

3/6

Future Growth Score 3/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


19.7%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: ELMD's forecast earnings growth (19.7% per year) is above the savings rate (1.9%).

Earnings vs Market: ELMD's earnings (19.7% per year) are forecast to grow faster than the US market (14.8% per year).

High Growth Earnings: ELMD's earnings are forecast to grow, but not significantly.

Revenue vs Market: ELMD's revenue (12.4% per year) is forecast to grow faster than the US market (7.7% per year).

High Growth Revenue: ELMD's revenue (12.4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if ELMD's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Past Performance

How has Electromed performed over the past 5 years?

Past Performance Score

2/6

Past Performance Score 2/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


6.5%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: ELMD has high quality earnings.

Growing Profit Margin: ELMD's current net profit margins (5.5%) are lower than last year (6.6%).


Past Earnings Growth Analysis

Earnings Trend: ELMD's earnings have grown by 6.5% per year over the past 5 years.

Accelerating Growth: ELMD's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: ELMD had negative earnings growth (-2.4%) over the past year, making it difficult to compare to the Medical Equipment industry average (-0.2%).


Return on Equity

High ROE: ELMD's Return on Equity (6.7%) is considered low.


Discover strong past performing companies

Financial Health

How is Electromed's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: ELMD's short term assets ($34.5M) exceed its short term liabilities ($7.2M).

Long Term Liabilities: ELMD's short term assets ($34.5M) exceed its long term liabilities ($41.0K).


Debt to Equity History and Analysis

Debt Level: ELMD is debt free.

Reducing Debt: ELMD has no debt compared to 5 years ago when its debt to equity ratio was 6%.

Debt Coverage: ELMD has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: ELMD has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Dividend

What is Electromed current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage

Dividend Yield vs Market

Electromed Dividend Yield vs Market
How does Electromed dividend yield compare to the market?
SegmentDividend Yield
Company (Electromed)n/a
Market Bottom 25% (US)1.7%
Market Top 25% (US)4.7%
Industry Average (Medical Equipment)1.9%
Analyst forecast in 3 Years (Electromed)n/a

Notable Dividend: Unable to evaluate ELMD's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ELMD's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if ELMD's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ELMD's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as ELMD has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

1.0yrs

Average management tenure


CEO

Kathleen Skarvan (66 yo)

8.83yrs

Tenure

US$1,172,357

Compensation

Ms. Kathleen S. Skarvan has been the Chief Executive Officer of Electromed, Inc. since December 1, 2012 and its President since August 28, 2015. She is Independent Director of Citizens Community Bancorp, I...


CEO Compensation Analysis

Kathleen Skarvan's Compensation vs Electromed Earnings
How has Kathleen Skarvan's remuneration changed compared to Electromed's earnings?
DateTotal Comp.SalaryCompany Earnings
Jun 30 2022n/an/a

US$2m

Mar 31 2022n/an/a

US$2m

Dec 31 2021n/an/a

US$2m

Sep 30 2021n/an/a

US$2m

Jun 30 2021US$1mUS$410k

US$2m

Mar 31 2021n/an/a

US$3m

Dec 31 2020n/an/a

US$4m

Sep 30 2020n/an/a

US$4m

Jun 30 2020US$748kUS$410k

US$4m

Mar 31 2020n/an/a

US$4m

Dec 31 2019n/an/a

US$4m

Sep 30 2019n/an/a

US$3m

Jun 30 2019US$868kUS$397k

US$2m

Mar 31 2019n/an/a

US$2m

Dec 31 2018n/an/a

US$2m

Sep 30 2018n/an/a

US$2m

Jun 30 2018US$724kUS$345k

US$2m

Mar 31 2018n/an/a

US$2m

Dec 31 2017n/an/a

US$2m

Sep 30 2017n/an/a

US$2m

Jun 30 2017US$577kUS$285k

US$2m

Mar 31 2017n/an/a

US$2m

Dec 31 2016n/an/a

US$1m

Sep 30 2016n/an/a

US$2m

Jun 30 2016US$747kUS$238k

US$2m

Compensation vs Market: Kathleen's total compensation ($USD1.17M) is above average for companies of similar size in the US market ($USD774.31K).

Compensation vs Earnings: Kathleen's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.


Leadership Team

Experienced Management: ELMD's management team is not considered experienced ( 1 years average tenure), which suggests a new team.


Board Members

Experienced Board: ELMD's board of directors are considered experienced (5.1 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ELMD?
Owner TypeNumber of SharesOwnership Percentage
Hedge Funds521,6936.2%
Individual Insiders1,959,39723.1%
Institutions2,730,45532.2%
General Public3,263,89338.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 56.74% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
6.94%
Stephen Craney
587,901$6.0m0%no data
6.89%
George Winn
583,691$6.0m0%no data
6.16%
Summers Value Partners
521,693$5.3m2.89%no data
5.6%
Bradley Radoff
475,000$4.9m0%no data
4.99%
Punch & Associates Investment Management, Inc.
423,117$4.3m-3.12%0.31%
3.64%
The Vanguard Group, Inc.
308,456$3.2m-0.56%no data
3.23%
Dimensional Fund Advisors LP
273,567$2.8m1.81%no data
3.17%
Acadian Asset Management LLC
269,025$2.8m-0.48%0.01%
2.55%
Joh. Berenberg, Gossler & Co. KG, Asset Management Arm
216,339$2.2m0%0.07%
2.23%
Kathleen Skarvan
189,305$1.9m16.03%no data
1.28%
Bridgeway Capital Management, LLC
108,738$1.1m2.26%0.03%
1.17%
Royal Bank of Canada, Banking & Securities Investments
99,556$1.0m0.31%no data
1.14%
White Pine Capital, LLC
96,432$988.4k-9.02%0.41%
1.14%
BB&T Trust
96,252$986.6k0%no data
0.81%
Hunter Associates, Inc.
68,400$701.1k-60.69%0.18%
0.8%
Radoff Family Foundation, Endowment Arm
67,500$691.9k0%13.81%
0.72%
Renaissance Technologies LLC
60,904$624.3k-21.21%no data
0.67%
Millennium Management LLC
56,736$581.5k-8.41%no data
0.62%
Geode Capital Management, LLC
52,554$538.7k-0.27%no data
0.6%
Friess Associates, LLC
50,614$518.8k-23.56%0.82%
0.56%
Charles Schwab Investment Management, Inc.
47,832$490.3k-25.17%no data
0.54%
GlobeFlex Capital LP
45,613$467.5k-50%0.09%
0.49%
GAMCO Investors, Inc.
41,928$429.8k0%no data
0.41%
Teton Advisors, LLC
35,142$360.2k0%0.07%
0.39%
BNY Mellon Asset Management
32,695$335.1k0%no data

Company Information

Electromed, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Electromed, Inc.
  • Ticker: ELMD
  • Exchange: NYSEAM
  • Founded: 1992
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: US$86.873m
  • Shares outstanding: 8.48m
  • Website: https://smartvest.com

Number of Employees


Location

  • Electromed, Inc.
  • 500 Sixth Avenue NW
  • New Prague
  • Minnesota
  • 56071
  • United States


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ELMDNYSEAM (NYSE MKT LLC)YesCommon StockUSUSDAug 2010

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/10/01 00:00
End of Day Share Price2022/09/30 00:00
Earnings2022/06/30
Annual Earnings2022/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.